1995 Results from Slovakofarma

9 June 1996

- The Slovakian pharmaceutical company Slovakofarma has reported gross profits of 929.3 million Slovak koruna ($30.4 million) in 1995, an increase of 38% over the previous year. S L Pharma Holding of Vienna, Austria, acquired a majority stake of 79% in the company in 1994. The firm reported record sales of $130 million in 1995, 30% of which went to the domestic market. Exports were lower last year but the company did not give details. It exports to 26 countries, with 56% of this trade going to the Czech Republic.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight